These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19144981)

  • 1. Studies of the immune response in heparin-induced thrombocytopenia.
    Warkentin TE; Sheppard JA; Moore JC; Cook RJ; Kelton JG
    Blood; 2009 May; 113(20):4963-9. PubMed ID: 19144981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The temporal profile of the anti-PF4/heparin immune response.
    Greinacher A; Kohlmann T; Strobel U; Sheppard JA; Warkentin TE
    Blood; 2009 May; 113(20):4970-6. PubMed ID: 19109231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
    J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.
    Greinacher A; Juhl D; Strobel U; Wessel A; Lubenow N; Selleng K; Eichler P; Warkentin TE
    J Thromb Haemost; 2007 Aug; 5(8):1666-73. PubMed ID: 17488345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
    Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
    Amiral J; Wolf M; Fischer A; Boyer-Neumann C; Vissac A; Meyer D
    Br J Haematol; 1996 Mar; 92(4):954-9. PubMed ID: 8616093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?
    Warkentin TE; Sheppard JA; Moore JC; Moore KM; Sigouin CS; Kelton JG
    J Lab Clin Med; 2005 Dec; 146(6):341-6. PubMed ID: 16310517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
    Newman PM; Chong BH
    Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia.
    Lindhoff-Last E; Gerdsen F; Ackermann H; Bauersachs R
    Br J Haematol; 2001 Jun; 113(4):886-90. PubMed ID: 11442479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
    Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
    J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
    Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
    Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
    Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
    Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PF4-heparin immunoglobulin G is the major class of heparin-induced thrombocytopenia antibody: findings of an enzyme-linked immunofiltration assay using membrane-bound hPF4-heparin.
    Vun CM; Evans S; Chesterman CN
    Br J Haematol; 2001 Jan; 112(1):69-75. PubMed ID: 11167786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.